Gilead Sciences Inc (GILD)

94.11 -0.30 (-0.32%) USD  |  NASDAQ  |  Dec 27, 16:00
94.15 +0.04 (+0.04%) After-Hours: 20:00
More

Gilead Sciences SG&A Expense (Quarterly): 1.433B for Sept. 30, 2024

SG&A Expense (Quarterly) Chart

View SG&A Expense (Quarterly) for GILD.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View SG&A Expense (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

SG&A Expense Definition

View SG&A Expense Definition
Start Trial

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (Quarterly) Range, Past 5 Years

View SG&A Expense (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

SG&A Expense (Quarterly) Benchmarks

View SG&A Expense (Quarterly) Benchmarks
Start Trial
Merck & Co Inc 2.731B
Pfizer Inc 3.244B
AbbVie Inc 4.205B
Eli Lilly and Co 2.100B
Amgen Inc 1.625B